[ad_1]
Seegene, a molecular diagnostics company, achieved its highest quarterly performance in the third quarter of this year on the back of a strong new coronavirus infection diagnostic kit business (Corona 19).
Seegene logo
Seegene announced on the 11th that it had a consolidated turnover of 3269 billion won, an operating profit of 209.9 billion won and a net profit of 152.5 billion won in the third quarter of this year.
Sales of Seegene in the third quarter of this year increased 941% from 31.4 billion won in sales in the same period last year.
Operating profit jumped 2967% from 6.8 billion won. Net profit increased by 2486%.
A Seegene official said: “With the explosion in demand for Corona 19 related products in Europe, sales have also increased by about 20% compared to the second quarter.” It registered and exceeded expectations, “he said.
The cumulative sales of Seegene in the third quarter of this year were 683.5 billion won and its cumulative operating profit was 418.6 billion won.
Seegene expected earnings to continue to improve in the fourth quarter.
A Seegen official said: “(In the fourth quarter), we expect better results than in the third quarter.”
Reporter Shin Hyeyeon [email protected]
[ad_2]
Source link
